SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001604867-24-000006
Filing Date
2024-02-14
Accepted
2024-02-14 10:47:17
Documents
1

Document Format Files

Seq Description Document Type Size
1 fenc_13g_2024v3.htm SC 13G 69335
  Complete submission text file 0001604867-24-000006.txt   71190
Mailing Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709
Business Address PO BOX 13628 68 TW ALEXANDER DRIVE RESEARCH TRIANGLE PARK NC 27709 (919) 636-4530
FENNEC PHARMACEUTICALS INC. (Subject) CIK: 0001211583 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-80470 | Film No.: 24633922
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 1063 POST ROAD 2ND FLOOR DARIEN CT 06820
Business Address 1063 POST ROAD 2ND FLOOR DARIEN CT 06820 203-625-1300
Solas Capital Management, LLC (Filed by) CIK: 0001604867 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G